Fantasista Co., Ltd.
Notice Regarding Cessation of Operations of a Consolidated Subsidiary, Recording of Extraordinary Loss and Revision of Earnings Forecast
Fantasista Co., Ltd. will cease the raw material wholesale business of its consolidated subsidiary Hundred Years, and record an extraordinary loss including inventory valuation loss. Accordingly, the consolidated earnings forecast for the fiscal year ending September 2026 has been revised. Sales of 5-ALA related products will continue, and partnerships with other companies are progressing.
Key Figures
- Revised consolidated net sales: 4,640 million yen
- Revised consolidated operating income: 361 million yen
- Revised net income attributable to owners of parent: -570 million yen
AI要約
Summary of Performance
Due to the resolution passed today to terminate operations of a consolidated subsidiary, the raw material wholesale business of Hundred Years Co. will be discontinued. In connection with this, a total of 597 million yen is being recorded as a business restructuring loss, including inventory valuation losses. Concurrently, the consolidated earnings forecast for the fiscal year ending September 2026 has been revised to net sales of 4,640 million yen, operating income of 361 million yen, ordinary income of 292 million yen, net loss of -570 million yen, and net income per share of -3 yen 15 sen.
Future Business Policy and Impact
Sales of 5-ALA related products will continue, with efforts to strengthen sales of existing products, launch new products, and expand distribution channels via ODM/OEM to improve the profitability of the healthcare business. Disposal of 5-ALA raw materials held by Hundred Years Co. will proceed sequentially, and sales of 5-ALA related products will continue through that company and FF Co. Through a capital and business alliance with Eiwa Sangyo, future land utilization projects are also expected to advance.
Fantasista Co., Ltd.
Company overview · Stock price · Financial data · All IR
